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The potential benefits of using population isolates in genetic mapping, such as reduced genetic, phenotypic and
environmental heterogeneity, are offset by the challenges posed by the large amounts of direct and cryptic relat-
edness in these populations confounding basic assumptions of independence. We have evaluated four represen-
tative specialized methods for association testing in the presence of relatedness; (i) within-family (ii) within- and
between-family and (iii) mixed-models methods, using simulated traits for 2906 subjects with known genome-
wide genotype data from an extremely isolated population, the Island of Kosrae, Federated States of
Micronesia. We report that mixed models optimally extract association information from such samples, demon-
strating 88% power to rank the true variant as among the top 10 genome-wide with 56% achieving genome-wide
significance, a >80% improvement over the other methods, and demonstrate that population isolates have similar
power to non-isolate populations for observing variants of known effects. We then used the mixed-model method
to reanalyze data for 17 published phenotypes relating to metabolic traits and electrocardiographic measures,
along with another 8 previously unreported. We replicate nine genome-wide significant associations with
known loci of plasma cholesterol, high-density lipoprotein, low-density lipoprotein, triglycerides, thyroid stimu-
lating hormone, homocysteine, C-reactive protein and uric acid, with only one detected in the previous analysis of
the same traits. Further, we leveraged shared identity-by-descent genetic segments in the region of the uric acid
locus to fine-map the signal, refining the known locus by a factor of 4. Finally, we report a novel associations for
height (rs17629022, P < 2.13 1028).
INTRODUCTION
Isolated populations have a long history in genetic mapping
studies of inherited disorders with advantages including
reduced environmental, phenotypic and genotypic heterogen-
eity when compared with outbred populations (1–9). In par-
ticular, the reduction in genotypic heterogeneity observed in
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isolated populations due to founder effects, bottlenecks and
genetic drift, may allow otherwise rare mutant alleles to rise
to a higher frequency in these populations while at the same
time narrowing the spectrum of candidate mutations (10,11).
The increased chance for homozygosity has been a key
factor in identifying mutations responsible for rare monogenic
diseases in isolated populations (3,12,13). Here we investigate
the advantages and limitations of exploiting homozygosity in
isolated populations for the analysis of alleles effecting
complex traits (14–16). Genome-wide association studies
(GWAS) performed in outbred populations have thus far
identified many common variation contributing to complex
diseases (17). One limitation in these studies is that rare var-
iants that are not in linkage disequilibrium with the common
variants assayed are usually not detected (18). However,
when the populations analyzed in a GWAS have a substantial
number of individuals that share a recent common ancestor,
not only common variants (19,20), but sometimes also
rare variants affecting complex disorders can be identified
(21–23).
Genetic analysis of isolated populations pose unique chal-
lenges for traditional GWAS methods that have been mainly
focused on outbred populations (24). The crux of the differ-
ence is that in isolated populations the likelihood of any two
individuals in the population to be related is not negligible.
The resulting direct and cryptic relatedness confounds assump-
tions of independence between genotypes of different individ-
uals, as well as between their heritable phenotypes. Isolated
populations therefore contain a large amount of cross-
individual correlations, which pose problems for most
mapping methods. Further, consanguinity may be present so
that two alleles in a random individual may also be corre-
lated. The hidden correlation in the data can cause an over-
dispersion of the naı¨ve test scores for association and
consequently, false positive associations. Hence, the major
challenge for performing GWAS in isolated populations is
to account for this non-random intra- and inter-individual
correlation.
Although standard association tests assume independence of
genotypes and phenotypes across samples, several specialized
approaches for association do account for underlying related-
ness expected in isolated populations. In this work, we set
out to select and evaluate different methods to map complex
traits in an isolated, founder population. Many methods exist
that rely on knowledge of the underlying family structure in
the population. These approaches overcome the confounding
effects of non-random correlation via deconstruction of the
population into family units and the analysis of association
independently within each unit (within family variance)
(25–27). Some of these ‘family-based’ methods can be
extended by adding the variance between families to the
within family variance (28–32). A different type of
‘population-based’ approach does not utilize prior knowledge
of family structure, but rather explicitly models the relatedness
between all pairs of individuals based on their genotypes, and
incorporates this variance into a mixed model for association
(30,33–38). Such models have recently been extended to
genome-scale human studies and have been shown to effec-
tively control for population structure (37,38). Here our
emphasis is on the evaluation of such methods in the context
of extensive relatedness in study samples. We compared the
performance of four representative methods that account dif-
ferently for relatedness while testing for genome-wide associ-
ation: (i) focusing on allele transmission to offspring within
families (25) (ii) measuring association within as well as
between families (28,29,32) and finally (iii) capturing the
relatedness between all individuals in the population to con-
struct a mixed model to test for association (37). Our simu-
lations showed the mixed-model method to have increased
statistical power to detect association, offering a 1.8–2-fold
improvement over the family-based approaches.
As a proof of principle, we then used the mixed-model
method for genome scans relating to metabolic traits and elec-
trocardiographic measures in 2906 related individuals from the
Island of Kosrae, Federated States of Micronesia, who were
previously genotyped for over 350 000 SNPs. We reanalyzed
data for 17 phenotypes previously studied in this cohort
(19,39), along with 8 additional phenotypes. As positive con-
trols, we observe nine genome-wide significant associations
with known loci of measured levels of plasma cholesterol,
high-density lipoprotein (HDL), low-density lipoprotein
(LDL), triglycerides (TGs), thyroid stimulating hormone
(TSH), homocysteine (HOMO), C-reactive protein (CRP)
and uric acid, with only one detected in previous analysis of
the same traits (19). In addition, we refined a broad signal
peak for uric acid levels (chr11:59.1–65.3 Mb) by analysis
of identity-by-descent (IBD) shared genetic segments that
underlie the peak and dissected the full set of long-range
shared haplotypes in this region. We identified a single 3%
carrier frequency haplotype that accounted for all the signal
in the region, and replicated one of the two previously
known signals, refining that signal by a factor of 4. Finally,
we show a region of novel association for height (HGT)
(rs17629022, P , 2.1 × 1028).
RESULTS
Computational performance
Five representative programs for performing association in the
context of relatedness [family-based association test (FBAT),
FBAT+Wald, a family-based test of association with quanti-
tative phenotypes offered in the PLINK framework (PLINK/
QFAM-total), efficient mixed model association expedited
(EMMAX) and sequential oligogenic linkage analysis routines
(SOLAR)] were assessed for speed and maximum memory
allocation to determine their suitability for a genome-scale
association analysis across thousands of individuals. The
average computation time for association per marker for
each program is given in Table 1. FBAT, FBAT+Wald,
EMMAX and PLINK/QFAM-total ran at speeds ,0.06 s/
SNP, with FBAT performing .2-fold faster than the other
three methods, compared with the SOLAR method which
was .100-fold slower. The slow speed of the SOLAR
method prohibited its further inclusion in the study. The
maximum virtual memory allocation required by the remain-
ing three methods did not exceed 1.7 GB of RAM during the
runtime of each program.
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Comparison of method accuracy and efficacy on
known-answer data
We evaluated the performance of different approaches to
genome-wide association in the context of relatedness by com-
paring representative tools for each approach. The family-
based association test (FBAT) is a method that considers
allele transmission to offspring within families (25). The
FBAT group has recently suggested an extension of their
method that combines the within-family FBAT score with a
rank-based, between-family score, derived from a Wald test
of the whole cohort, that is robust to overdispersion, into
one single test statistic (FBAT+Wald), which we also tested
(32). Plink QFAM for quantitative traits, within- and between-
mode (PLINK/QFAM-total), uses a linear regression-based
between/within family approach similar to a model described
previously (26,40). In the PLINK/QFAM-total framework,
confounding effects of family structure are controlled by inde-
pendent within- and between-family permutation strategies for
estimating exact significance levels, where the empirical
within- and between-family permuted P-values are combined
to a single score. We corrected for any residual overinflation
of the test statistic by standard genomic control adjustment
(28,29). Finally, EMMAX is a method that first uses high-
density genotypes to empirically estimate levels of relatedness
between every pair of individuals, which are captured in a
kinship matrix. The kinship matrix is then incorporated into
a linear mixed model to adjust for correlation in the phenoty-
pic distribution during association mapping (37). We used all
four methods to perform genome-wide association analysis in
a highly related, population-based cohort from the Island of
Kosrae, Micronesia, that is comparable in size (n ¼ 2906) to
published single study case/control cohorts.
In order to assess the empirical power for each association
method, we considered data for over 350 000 SNPs, with a
minor allele frequency (MAF) .0.01, genotyped on an Affy-
metrix 500K platform in the Kosrae samples. We repeatedly
analyzed association of these SNPs to a null, moderately heri-
table (h2 ¼ 0.42 on Kosrae) phenotype, body mass index
(BMI), which we modified afresh multiple times. Each modi-
fied phenotyped included a simulated genotype/phenotype
association explaining 2% of the phenotypic variance to a
different random SNP, additively combined to the true trait
value. This effect size was chosen to echo milder effects
detected and detectable in larger-sample studies that are now
available. These data sets were constructed by selecting
1000 SNPs randomly across the genome (770 common SNPs
after filtering, see Materials and Methods), where each
phenotype was altered to reflect association with a different
SNP in the random subset. In total, 770 genome-scale data
sets containing modified SNP-phenotype association were gen-
erated and analyzed by all four methods.
Following extensive pedigree construction based on genetic
and oral information, .90% of the genotyped individuals on
Kosrae form a single extended pedigree spanning 5+ gener-
ations and containing numerous consanguineous offspring and
multiple marriage loops (19). To the best of our knowledge,
large pedigrees with such complexity cannot be handled
whole by methods that have a within-family component.
Therefore, we broke our pedigree into smaller units of
sibships-without-parents for the purposes of method compari-
son. This resulted in 586 sibships consisting of two or more
individuals who share a mother and father (Fig. 1A). Any gen-
otyped parents are considered only in the context of the parents’
sibship. Of the individuals not included in any sibship (n ¼
612), a subset was identified in which any two members of
the subset were related to the degree of first cousins or less,
as determined by genome-wide identity-by-descent sharing,
resulting in 240 additional ‘sibships’ of size 1. To fairly
compare FBAT and PLINK/QFAM-total to EMMAX and
FBAT+Wald, we first analyzed only sibship individuals.
However, to also quantify the benefits of using the entire data
set, we repeated the analysis examining the entire cohort with
EMMAX and the sibships for the FBAT and entire cohort for
the Wald components of the FBAT+Wald method.
The empirical power for each method was recorded in
two ways; the reported (i) genome-wide rank (Fig. 2A) and
(ii) P-value (Fig. 2B) of the ground-truth SNP according to
each method across repeated simulation iterations. While
these criteria are equivalent when reported P-values are uni-
formly distributed (as required by the definition of a
P-value), inclusion of both criteria facilitates evaluation of
potential bias in such distributions. Comparison of the within-
family only (FBAT) versus combined within- and between-
family (PLINK/QFAM-total and FBAT+Wald) versus mixed
model (EMMAX) tests demonstrated that the greatest power,
as measured by rank order of the true effect, was obtained by
the use of the mixed-model method. EMMAX had 88%
power to rank the true SNP in the top 10 genome-wide, a
1.7-, 2- and 2.1-fold improvement over PLINK/QFAM-total,
FBAT and FBAT+Wald, respectively (Fig. 2A). In addition,
56% of truly associated SNPs achieved genome-wide signifi-
cance (gws) for the mixed-model method compared with
,16% for the other methods (Fig. 2B—see Discussion).
Although, the inclusion of the entire cohort (an additional
300 individuals that did not fall into sibships) in the FBAT+
Wald method increased the number of truly associated SNPs
that achieved gws to 21%, this was less than half of the gws
SNP’s EMMAX detected. The improvement in power was
also observed in comparison of the PLINK/QFAM-total naive
test scores (i.e. not adjusted for genomic control) with
EMMAX, indicating that the dampening effect of the lambda
correction does not account for the total power difference
between the two methods (Fig. 2B). Finally, the EMMAX
analysis of the entire cohort showed a further 1.2-fold increase
in power for the top 10 ranked ground truth SNPs, with an
additional 10% of SNP’s surpassing gws compared with the
EMMAX analysis of the sibships.
Table 1. Computation time (average computation time per second per SNP)
and maximum memory allocation (megabytes of RAM) for each association
methods (FBAT, FBAT+WALD, PLINK/QFAM-total, EMMAX and SOLAR)
FBAT FBAT+Wald PLINK/
QFAM-total
EMMAX SOLAR
Speed (sec/
SNP)
0.013 0.021 0.057 0.039 8.74
Memory (MB
RAM)
1660 1660 760 790 3200
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Results from the genome-wide association analysis of 25
metabolic and electrocardiographic traits
On the basis of our observations from the simulated data, we
selected the mixed-model method as the most powerful
method for analyzing our study population. We first built a
kinship matrix of pairwise identity-by-state metrics based on
high-density markers for the entire pedigree, which was incor-
porated into the mixed model for association mapping (37).
We analyzed 25 metabolic and electrocardiographic traits,
using measurements from 3 clinical screenings carried out
on Kosrae in 1994, 2001 and 2003 (19,39). The details of
the phenotypes, including population means, trait heritabil-
ity’s, covariate and score inflation adjustments, are given in
Supplementary Material, Tables S1 and S2 and (19,39). We
had previously published the results of the genome-wide
association analysis of 17 of these traits using the PLINK/
QFAM-total framework (19,39). Here, we reanalyzed data
for these 17 published phenotypes using the EMMAX frame-
work, along with another 8 previously unreported phenotypes
from the island.
We observe minimal score inflation using the EMMAX
method where the inflation factor l is estimated to be in the
range from 1.03 to 0.96 for all 25 traits (Supplementary
Material, Table S1). This contrasts with previously reported
l values that are significantly .1 for a subset of the traits ana-
lyzed using PLINK/QFAM-total (l range: 2.05–1.10) (19).
We note that genome-wide analysis with l ¼ 1.1 inflation of
P-values results in a 4.8-fold increase in the expected
number of false-positive results attaining gws, with practical
implication for the feasibility of follow-up.
Table 2 provides the top SNP per region emerging genome-
and study-wide significant from the EMMAX analysis of all 25
traits. We determined a gws threshold based on 310 k effec-
tive independent tests (3502320 k actual tests) to be 1.6 ×
1027 (see Materials and Methods). As positive controls, we
observed associations to eight genomic regions for seven
traits exceeding our gws threshold. Top SNPs are in or near
to known loci for plasma cholesterol (APOE; rs4420638,
P ≤ 1.47 × 10217), HDL (CETP; rs1800775, P ≤ 7.03 ×
1029), LDL (APOE; rs4420638, P ≤ 1.47 × 10223), TGs
(APOC3/A5; rs7396835, P ≤ 2.42 × 10212), TSH (FOXE1;
rs1877431, P ≤ 6.32 × 10214), HOMO (NOX4; rs1836883,
P ≤ 1.3 × 1028) and CRP (APOE; rs4420638, P ≤ 6.16 ×
10213 and CRP; rs3093077, P ≤ 7.10 × 1029) (41–47).
These eight regions are shown in detail in Figure 3A. Five
of these signal peaks also surpass our study-wide significance
threshold of 6.4 × 1029 (see Materials and Methods). Only
one of these positive controls had been detected at gws in
the previous analysis of the same traits via PLINK/QFAM
method; TGs (APOC3/A5; rs7396835, P ≤ 1.2 × 1029) (19).
In addition we observe two other known positive controls sig-
nificant at FDR ,0.3 (Supplementary Material, Table S5);
LDLs (HMGCR; rs3846663, P ≤ 8.77 × 1027) and HDL
(APOE; rs4420638, P ≤ 6.33 × 1027) (41,48).
To examine the genetics of common traits on Kosrae when
compared with outbred populations, we assessed the effect
sizes of known loci observed in our study. Specifically, we
identified 53 established associations in large, mainly Cauca-
sian studies across seven traits (BMI, CRP, HDL, HGT,
LDL, TG and URT), where the associations had sufficiently
high effect size and/or allele frequency to be detectable at
nominal significance in the 3000-strong Kosrae study (Sup-
plementary Material, Table S4) (41,47–55). For SNPs not
directly typed on the Affymetrix array, association results
are reported for a proxy on the Affymetrix chip with strong
correlation (r2. 0.95) to the original SNP in both HapMap
Caucasian (CEU) and Asian [Han Chinese (CHB), Chinese
in Denver (CHD), Japanese (JPT) and Gujarati Indians
(GIH)] panels. Of the 53 SNPs, only 21 had signals that
were detectable on Kosrae at nominal significance, indicating
Figure 1. Schema of the sibship and kinship matrix-based approaches to
association studies in related cohorts (A) The extended Kosrae pedigree is
broken into sibships without parents (indicated by the dotted gray circles).
Parent-child or cousin relationships may exist between different sibships.
Tests of association may be performed within sibships (gray arrows) and
between sibships (black arrows). (B) A kinship matrix of all pairs of the
same individual.
830 Human Molecular Genetics, 2011, Vol. 20, No. 4
that more than half the associated SNPs were tagging causal
variants that were either too rare to be detected or not
present on the Island. Sixteen of the 21 detectable signals on
Kosrae had effects in the same direction as observed for
those makers in the Caucasian cohorts (P , 0.01), and 5
were in the opposite direction. Of the former set of 16
SNPs, 12 showed stronger effect sizes on Kosrae, a greater
number than expected by chance (P , 0.027). However, in
this comparison, we cannot rule out the possibility that
effect sizes may be inflated upward due to winners curse, con-
founding this estimation.
We observed two interesting genome-wide significant
signals, one strong signal for uric acid levels that resides
.500 kb upstream of two independent known associations
(rs2186571, P , 1.8 × 10234), and one signal for HGT
which represented a novel association in the Kosraen cohort
(rs17629022, P , 2.1 × 1028) (Supplementary Material, Fig.
S3A and Fig. 3B, respectively). The novel SNP rs17629022
for HGT has a MAF of 0.06 and a strong effect size of 0.48
standard deviations per allele (for normalize z-scores, m ¼ 0,
s ¼ + 1). This corresponds to an average 1.28′′ (95% confi-
dence intervals: 0.97′′ –1.66′′) and 4.23′′ (95% confidence
interval: 2.48′′ –5.97′′) average increase in HGT in carriers
(n ¼ 271) and minor allele homozygotes (n ¼ 13), respect-
ively, compared with major allele homozygotes. The SNP
resides on chromosome 17q21 in a gene-rich region containing
GAP, CCDC103 and FAM187A. In all, of the 10 hit SNPs
associated via the EMMAX method, two were also found to
Figure 2. Empirical estimation of power of association for four representative association methods for related cohorts (A) The aggregate rank of the ground truth
SNP across 770 simulated data set for association performed with FBAT, FBAT+Wald, PLINK/QFAM-total+genomic control and EMMAX with sibship struc-
tured (n ¼ 2007), simulated data sets and FBAT+Wald and EMMAX with all individuals (n ¼ 2317), simulated data sets. (B) The aggregate P-values of the
ground truth SNP for association performed with FBAT, FBAT+Wald, Plink/QFAM-total+genomic control, Plink/QFAM-total without genomic control and
EMMAX with sibship structured, simulated data sets and FBAT+Wald and EMMAX with all individuals, simulated data sets.
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Table 2. Genome- and study-wide significant SNPs from the analysis of 25 traits
Trait na CHR POS
(MB)b
SNP A1c A2d MAF effect size % varg EMMAX
(P-value)
FBAT
(P-value)
FBAT+WALD
(P-value)
PLINK/QFAM
(P-value)
Gene regionh
be s.e.f
TC 2753
19 45.4 rs4420638 G A 0.182 0.274 0.033 2.42 1.47 × 10217 3.43 × 1025 2.31 × 1025 3.43 × 1027 APOC1/APOE/
TOMM40
LDL 2775
19 45.4 rs4420638 G A 0.182 0.316 0.033 3.24 2.57 × 10223 7.54 × 1025 1.72 × 1024 1.91 × 1027 APOC1/APOE/
TOMM40
HDL 2774
16 57.0 rs1800775 A C 0.394 0.183 0.026 1.82 7.03 × 1029 4.32 × 1025 3.21 × 1024 5.82 × 1025 CETP
TG 2754
11 116.7 rs7396835 T C 0.372 0.214 0.026 2.36 2.42 × 10212 4.33 × 1027 2.31 × 1028 1.22 × 1029 APOA5/APOCIII
CRP 1872
19 45.4 rs4420638 G A 0.182 20.318 0.041 3.05 6.16 × 10213 8.56 × 1026 1.02 × 1026 1.60 × 1026 APOC1/APOE/
TOMM40
1 159.7 rs3093077 C A 0.247 0.245 0.037 2.25 7.10 × 1029 5.41 × 1022 2.11 × 1023 2.31 × 1023 CRP
HOMO 1870
11 89.3 rs1836883 T C 0.321 0.210 0.036 1.75 1.29 × 1028 6.99 × 1024 5.67 × 1024 1.17 × 1028 NOX4
TSH 1858
9 100.5 rs1877431 A G 0.224 20.299 0.037 3.46 6.32 × 10214 1.10 × 1022 3.21 × 1023 3.5 × 1026 FOXE1
HGT 2364
17 43.0 rs17629022 C T 0.064 0.481 0.058 2.83 2.00 × 1028 8.36 × 1023 7.56 × 1023 1.72 × 1023 GFAP
URT 1861
11 63.9 rs2186571 A G 0.028 21.433 0.101 9.79 1.77 × 10234 4.20 × 10220 2.19 × 10218 2.11 × 10227 URAT1i
This table lists the top SNP in a genetic region for the association using the EMMAX method of 25 traits pertaining to metabolic syndrome and electrocardiographic conductance that surpasses genome-wide
significance (P ≤ 1.6 × 1027). SNPs that also surpassed study-wide significance (P ≤ 6.4 × 1029) are indicated in italics. P-values for association for the same SNPs using the other three methods tested in
this study are also given.
an, the number of phenotyped individuals for the trait.
bPOS(MB): chromosomal physical position in megabases; Genome Reference Consortium build 37 (GRCh37).
cA1, the minor allele.
dA2, the major allele.
eb, the effect size (linear mixed-model regression coefficient).
fs.e., the standard error of the effect size.
g%var, the percent variance explained (oneway ANOVA).
hCandidate genes in the region of the top SNP.
irs2186571 is .400 kb upstream of URAT1 (see Results for explanation).
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be associated with gws level by PLINK/QFAM and FBAT+
Wald; TGs (APOC3/A5; rs7396835, P ≤ 1.2 × 1029 and
P ≤ 2.3 × 1028, respectively) and urate (rs2186571, P ,
2.1 × 10227 and P ≤ 2.2 × 10218, respectively), and one by
FBAT; urate (rs2186571, P , 4.2 × 10220), see Table 2.
Analysis of the uric acid trait revealed a broad peak in the
genome scan on chromosome 11q13.1 (59.2–65.3 Mb) con-
taining 54 SNPs that surpassed the study-wide significance
threshold (Supplementary Material, Table S5 and Fig. S3A).
The top SNP, rs2186571, represents a novel association with
uric acid. rs2186571/A has a MAF of 0.028 and a strong
effect size of 21.14 standard deviations per allele, accounting
for 10% of uric acid level variance on Kosrae, where carriers
of rs2186571/A have a mean uric acid level of 3.6 mg/dl
compared with the major allele homozygotes level of
5.5 mg/dl. However, rs2186571 resides 500 kb upstream of
two variants on chromosome 11q13.1 recently found to be
associated with uric acid levels (56). To determine whether
the strong uric acid signal represented a novel observation or
might tag either of the previously observed signals, we per-
formed a haplotype-based fine-mapping of the signal region
and conditional analysis.
Fine mapping the interval of uric acid association
Common shared long-range haplotypes were detected via pair-
wise IBD genetic segment matching between all individuals in
the pedigree using the GERMLINE software (56). The IBD
Figure 3. Ten regions of genome-wide significant associations. (A) We observe eight genome-wide significant associations to known loci for plasma cholesterol
(TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (TGs), thyroid stimulating hormone (TSH), homocysteine (HOMO) and C-
reactive protein (CRP), with only one detected in the previous analysis of the same traits. (B) Region of novel association for height (HGT) (rs17629022, P,
2.1E-8). The trait and chromosomal location are given for each plot. The y-axis show’s –log10 P-value (LOD) and the x-axis shows the chromosomal physical
position in megabases. The maroon square represents the location of the top scoring SNP. The red and pale blue dashed lines indicate the genome- and study-wide
significance thresholds, respectively.
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segments were at least 3 cM in length and allowed for up to
1% mismatching due to genotyping error. IBD segments
were then clustered to groups of similar haplotypes, with
.500 kb overlapping sequence and sharing .99% sequence
identity, as described in detail previously (57). Clusters of
shared haplotypes were then independently mapped to uric
acid levels, which identified a single strong mapping cluster,
where the specific sharing boundaries of the haplotype
mapped to a 2 Mb sub-region (chr11:63.7–65.5) of the
uric acid GWAS signal peak (Supplementary Material,
Fig. S3A). This ‘uric acid haplotype’ (rs4980499 to
rs1074156) is unique to a group of 96 individuals (carrier fre-
quency 0.03), is strongly associated with uric acid (P ,
9.07 × 10246) and has an effect size of 22.12 standard devi-
ations per allele (accounting for 20% of uric acid level var-
iance on Kosrae; 95% confidence intervals 16.8–21.6%).
Conditioning the uric acid levels for the uric acid haplotype
effect abolishes signal at the rs218571 SNP (P , 0.83),
whereas a significant signal remains (P , 2.1 × 1025) at the
uric acid haplotype when the levels are adjusted for the
effect of rs218571 (Supplementary Material, Table S4).
Genome-wide scan of haplotype conditioned uric acid levels
reveals no remaining genome-wide significant signals (Sup-
plementary Material, Fig. S3B). Therefore, the uric acid hap-
lotype likely captures the full signal tagged by the top
GWAS SNP.
We next determined whether the uric acid haplotype rep-
resented a novel variant or a refinement of either of two
local previously shown uric acid variants, rs17300741 and
rs505802. The two known variants reside in/near organic
ion transporter 4 (OAT4) and urate transporter 1 (URAT1),
respectively, which are known candidate genes for renal
urate anion exchange and are thought to regulate blood uric
acid levels (58,59). Neither variant was directly assayed in
the Kosrae genotype panel. However, two assayed variants
on the 500 k Affymetrix chip, rs12362644 and rs10897518
that flank rs17300741 and rs505802, respectively, were
observed to be in complete linkage disequilibrium (r2¼ 1)
with each variant in all HapMap Asian panels (CHB, CHD,
JPT, GIH). We therefore concluded that rs12362644 and
rs10897518 genotyped on Kosrae would be strong tags for
the unobserved rs17300741 and rs505802 variants, respect-
ively. Indeed, signals for association were observed for
rs12362644 (P , 8.16 × 1025) and rs10897518 (P ,
3.41 × 10217), the latter being study-wide significant. Analy-
sis of the uric acid haplotype conditioned on rs12362644 and
rs10897518 abolished the signal at these two variants (P ,
0.41 and P , 0.93, respectively). However, the strong
signal at the uric acid haplotype persisted (P , 8.48 ×
10223). Conversely, when uric acid levels are conditioned
on the uric acid haplotype, a moderate signal for
rs12362644 (tagging rs17300741) remained 2.66 × 1023;
however, the signal at rs1087518 (tagging rs505802) was
abolished (P , 0.94) (Supplementary Material, Table S4),
indicating that, while there is some correlation between
rs12362644 and the uric acid haplotype, the haplotype
effect is not explained by the effect of rs12362644, but that
the variant tagged by rs10897518 is carried on the uric acid
haplotype background (Supplementary Material, Table S4).
Moreover, the comparing the 0.06 frequency of rs1087518
on Kosrae to the lower 0.015 frequency of the uric acid hap-
lotype indicates a refinement of the signal by a factor of 4,
dramatically reducing the sequence and sample search
space for pinpointing the underlying causal variant.
DISCUSSION
To determine which association method would be best
powered to analyze a highly related isolate population, we
compared four tests utilizing different approaches for captur-
ing underlying population structure. One of the methods
measured variance within family units and three of the
methods added the variance between families using different
strategies to control for the overinflation of the naı¨ve score
that resulted from the sample structure. Two of the approaches
uniformly rescaled the markers by adding a rank-based
P-value to a score or adjusting the score for overinflation by
genomic control. These approaches reduce false positives,
but also lead to decreased power for true positives. The mixed-
model approach modified the test statistic in a marker specific
way, which in turn changed the ranks of associated results, so
that false positives are reduced, but true positives did not
change. In our evaluation of four representative methods for
mapping disease alleles in highly related isolated populations,
we found that the mixed-model method significantly outper-
formed the other three methods. The power difference was
indeed in part due to the over-conservative uniform adjust-
ments, but they did not account for all the power difference
between the two methods. The kinship matrix incorporated
in the mixed model likely captured more between-family var-
iance than the other methods. Further, as the mixed-model
method was not restricted to families, an analysis across the
whole sample increased the power.
Handling hidden and direct relatedness in the context of a
mixed-model has both theoretical and practical advantages
over other approaches for association testing in closely knit,
isolated cohorts. Theoretically, it handles relatives distant
and close, demographic trends and complex pedigrees; vari-
ation both within and between families is utilized; and the
test statistic produced is uniformly distributed, with no artifi-
cial overdispersion of the P-value. Practically, the ability to
include all samples in the analysis gave a .2-fold boost in
power and our empirical results support the use of mixed
models for association in populations such as our samples.
Finally, the proof of the pudding is the analysis and reanalysis
of 25 biomedical traits from the island using the more power-
ful mixed-model approach yielding 10 significant hits, only
one of which had been detected by other methods. More
important were the discovery of a putative novel association
for HGT, and a novel long shared haplotype that accounts
for 20% variance in uric acid levels on the Island.
These two novel associations exemplify both the limitations
and opportunities for performing genetic mapping in isolated
populations. We demonstrate association for HGT in a
region not previously observed, despite multiple large-scale
genetic studies in Caucasians (59,60). It is possible that the
underlying mutation is of stronger effect or higher frequency
on the island, making it easier to detect, alternatively the
causal variant may also be Asian specific, or even private to
the island. If the latter case is true, then the signal is unlikely
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to be confirmed by replication. It should also be noted that the
signal for the HGT SNP did not reach study-wide significance
and could represent a false positive. On the other hand, we
observe an extremely strong signal for uric acid level, also
present in Caucasian populations, which we could refine by
a IBD-based haplotype fine-mapping facilitated by the abun-
dance of long shared haplotypes in isolated populations
(54,61). Further, as the uric acid haplotype tags only one of
the known variants, our finding supports independence
between the two reported signals in the region.
In conclusion, it is worthwhile reviewing our work in the
context of recent ideas and results in the association analysis.
Specifically, the emerging picture is that despite comprehen-
sive scans of association with common SNPs of multiple
complex phenotypes, only a limited fraction of their heritable
component has been identified (17,62). Expanding the search
for associated alleles to variants that are rare in the general
population provides another piece of this heritable component,
with multiple gene sequencing studies implicating such var-
iants with moderate to high penetrance (63–67). Our experi-
ences in association testing in an isolated population can
serve as a model for other studies of similar cohorts. Methodo-
logically, mixed models optimally extract association infor-
mation from such samples. More importantly, in terms of
study design and choice of cohort, we observe some of the pre-
viously theorized advantages and limitations of isolated popu-
lations. We showed that some variants that are associated with
traits in other populations do not replicate on Kosrae, due to
bottleneck effects rather than lack of power. On the other
hand, observed associations show strong effects and statistical
support for a cohort of this size, potentially due to increased
genetic and environmental homogeneity. Finally, as GWAS
cohorts increase in size to the six-digit range, and inclusion
of somewhat related individuals becomes a practical modus
operandi, results in this work are expected to become relevant
to a wide range of populations.
MATERIALS AND METHODS
Study population and phenotypes
A full description of the screening and genotyping of the
Kosraen cohort was described elsewhere (19). Briefly, we sur-
veyed 3148 highly related individuals from the Pacific Island
of Kosrae in three separate screenings carried out in 1994,
2001 and 2003, who represent .75% of the adult population
on the Island. Informed consent was obtained from each indi-
vidual screened and so were self-reported family histories and
lifestyle information. Fasting blood was collected and centri-
fuged. Plasma and buffy coats were frozen and shipped to
Rockefeller University, NY, for serological assays and DNA
extraction. Phenotypes were measured for 25 metabolic and
electrocardiographic traits. Seventeen traits which were pre-
viously described [total cholesterol, LDL, HDL, TG, CRP,
TSH, HGT, weight (WGT), waist circumference, BMI,
percent body fat, leptin hormone levels, fasting blood sugar,
systolic blood pressure, diastolic blood pressure, PR interval
and QRS interval] (19,32) and an additional eight traits
[insulin sensitivity, glomerular filtration rate, homocysteine
(HOMO), folic acid (FLT), uric acid (URT), Sokolow-Lyon
voltage, Cornell voltage and RR (inverse heart rate) interval
(RRD)] [Supplementary Material, Table S2 and (19,32) for
details]. IRB approval was obtained from all participating
institutions. A first pass reconstruction of the extended pedi-
gree of the 3000-strong cohort included denser sampling of a
further 1000 related non-genotyped individuals to fill out
the pedigree and careful cross-referencing of patient records.
More than 90% of the cohort formed a single extended 5+
generation pedigree. Genome-wide SNP data were subjected
to identity-by-state analyses and identity-by-descent esti-
mation performed in PLINK (29) to correct and validate the
pedigree structure. Full details of the pedigree construction
are described elsewhere (19).
Genotypes and quality control
A total of 2906 study participants were successfully genotyped
on the Affymetrix 500K platform; data were generated at
Affymetrix, South San Francisco, CA, USA. Genotypes were
called with the BRLMM algorithm and a minimum call rate
of 95% were achieved. A total of 446 802 SNPs passed
quality control filters and between 122K-91K SNPs that
were monomorphic or very rare (MAF ,0.01) for each pheno-
type were also excluded. The final data set yielded between
354 901 and 323 902 SNPs per phenotype with MAF .0.01
for the analysis (Supplementary Material, Table S1).
Data simulation
The performance for each association method was evaluated
by analyzing simulated data sets constructed from real BMI
phenotype data in which no genome-wide significant associ-
ations were found (19). For simulation, 1000 SNPs were ran-
domly selected from Kosraen 500 k Affymetrix genotypes
and 770 remained after filtering MAF .0.01. Using these
SNPs, we generated a total of 770 genome-scale (350 k
SNPs each) simulated data sets, in which each phenotype
(BMI) was ‘spiked’ to represent a dependency with one of
770 SNPs, which contains an effect explaining an additional
2% of phenotypic variance. Each simulated data set, compris-
ing 2906 Kosraen individuals, was deconstructed into a pedi-
gree of 586 sibships of size ≥2 plus 240 individuals who
were less than first cousins (a total of 2007 individuals) that
could be handled by all four methods. The four methods
(FBAT, FBAT+Wald, Plink/QFAM-total and EMMAX)
were used to perform association for each of the 770 sibship-
structured, simulated data sets. Finally, in order to assess the
full power of the both the FBAT+Wald and EMMAX
methods, the simulated data sets were also reanalyzed, this
time including an extra 310 individuals who did not fit into
the sibship pedigrees (n ¼ 2317).
Association methods
We performed comparative analysis for three different associ-
ation approaches: a within-family test versus two within- and
between-family tests versus a mixed-model test. We tested
each representative tool under additive models and with mod-
erate parameters to optimize the behavior of association
mapping. FBAT (version 2.0.2c) (25) was chosen to represent
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a within-family test. We set minsize to 3, which is the required
parameter of minimum size of family to include for analysis,
without loss of any data and biallelic test under an additive
model was performed with the default settings. We selected
two approaches that combine a within-family test with a
between-family score. The first was the QFAM-total procedure
implemented in the PLINK framework (plink version 1.05)
(29). We ran the within- and between-family test (–qfam-
total), combined with a 1 M permutations (–aperm 1 000
000) to calculate the within- and between-family permutation-
based combined empirical P-value. We also calculated any
overdispersion of the test statistic using the –adjust flag,
which adjusts the empirical P-value by the genomic control
inflation factor. The second within- and between-family test
was an extension of the FBAT test. For this we calculated a
‘screening statistic’ by first deriving a rank-based P-value
from a Wald test performed in Plink (–assoc) and we then
combined the FBAT and rank-based Wald score with equal
weights as outlined (32) to produce a FBAT+Wald score.
Finally, we selected EMMAX (pre-release beta version) for
representing a mixed-model method which theoretically can
handle all the relatedness of the cohort (34,37). We first calcu-
lated an identity-by-state kinship matrix for individuals using
the Affymetrix genotypes in EMMAX (emmax-kin –v –h
–s –d 10), and then added the kinship matrix to the mixed
model for association testing [emmax-kin –v –h –s –d 10
–k (kinship-matrix)] (37). As both FBAT and PLINK/QFAM-
total do not support association mapping in complex pedigree
structures, the pedigree was broken down into sibships
(siblings-without-parents) as described previously (19) and
these sibships were used for testing for the FBAT and
PLINK/QFAM-total association methods. For a fair compari-
son, the Wald score of the FBAT+Wald test was derived
using just sibships (FBAT+Wald_sibs) and the EMMAX
analysis was performed by using just the sibships both for
the construction of the kinship matrix and the mixed-model
association testing (EMMAX_sibs). For power quantification,
the FBAT+Wald and EMMAX analyses were repeated, this
time including an extra 310 individuals who did not fit into
the sibship pedigrees (n ¼ 2317). In the case of FBAT+Wald,
these extra individuals were added to the ‘screening statistic’
(FBAT+Wald_all), and for EMMAX the extra individuals
were used both to construct the kinship matrix and included
in the mixed model (EMMAX_all).
Association performance
We evaluated the performance of each method by two metrics.
First, a rank-based score measured the P-value rank of the
ground truth SNP in its own data set. We compared the aggre-
gate of rank of ground truth SNP for the four different associ-
ation methods and considered the one that assigns more high
ranks to ground truth SNPs to be the more powerful method.
The second metric was a P-value-based score, which measures
the P-value of the ground truth SNP in its respective data set.
With the sum of ground truth SNPs exceeding a particular
P-value threshold, we alternatively compared the power of
each method.
Association mapping on real data
EMMAX was selected for association study of real Kosraen
data. A total of 25 quantitative traits were adjusted for age
and gender effects, converted to z-scores and outliers (.3
standard deviations from the mean) were removed (Sup-
plementary Material, Tables S1 and S2). Low frequency gen-
otypes (MAF .0.01) were removed. A kinship matrix which
captured the relatedness between all pairs of genotyped indi-
viduals (n ¼ 2906) was incorporated into the EMMAX
mixed model to test for association with each trait. Minimal
score inflation was seen in the nominal P-values for all traits
(Supplementary Material, Table S1 and Fig. 2). The effect
size (b) is given as the difference in standard deviations
from the mean per allele and was calculated as the regression
coefficient of the linear mixed model. The percent variance
explained was calculated by oneway ANOVA. As there is a
high degree of linkage disequilibrium in our data, we deter-
mined a gws threshold by first extrapolating an approximate
testing burden from the trait data. The median minima
P-value from 14 null traits was 1.6 × 1026, indicating an esti-
mated testing burden of 310 000 (actual number of tests was
350–320 K). The gws threshold to account for multiple
testing for each trait was determined by Bonferroni correction
based on the estimated testing burden, i.e. 0.05/310 000 ¼ P ≤
1.6 × 1027. A study-wide significance threshold that also
accounts for testing multiple traits in the same study was deter-
mined conservatively using the Bonferroni correction: 1.6 ×
1027/25 ¼ P ≤ 6.4 × 1029.
Identifying haplotypes
Genotypes were phased using the BEAGLE-trio algorithm in
one run according to the recommended parameters: 1
sample, 10 iterations (68,69). Phased genotypes were then ana-
lyzed for pairwise IBD matching by the GERMLINE algor-
ithm (56) using the default parameters: minimum match
length of 3 cM, maximum 2 homozygote errors, 0 heterozy-
gote errors and window size of 128 markers. In other words,
haplotypes were registered whenever pairwise comparison
revealed a window of allele-call identity at least 3 cM in
length with up to 1% mismatch allowed for genotyping error.
Clustering haplotypes and haplotype-based association
Clustering GERMLINE-derived haplotypes has been pre-
viously described in detail (57). In brief, a set of individuals
that share any size overlap of genetic segments were first
identified, then the specific sharing boundary positions were
mapped between individuals in that set, and each set was
dubbed ‘a haplotype cluster’. A single individual can be a
member of maximum two haplotype clusters at any given
marker and multiple haplotype clusters across all markers in
the genome. A total of 93 629 distinct haplotype clusters
were identified after filtering for haplotype clusters of ≥0.01
frequency ≥500 kb in length. The haplotype clusters were
associated with uric acid levels using EMMAX (see above)
and a 13 genome-wide significant haplotypes spanning
chr11:36.2–94.2 Mb emerged (P , 8.52 × 1028), with a
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chr11: 63.4–65.2 sub-region being most significantly associ-
ated (P , 9.06 × 10246).
Computation
All analysis of the simulated data sets and real data were per-
formed on a 3.0 GHz Intel Xeon dual core 64-bit cluster con-
taining 100 nodes (with four processors each), where each
node had 8–16 GB of RAM.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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